Anna Baj
@bajanna451.bsky.social
Cancer Biology PhD student at Emory University : Future Scientist : Class of 2021 - Stetson University : Bassoon instrumentalist
I'm excited to share that my abstract was chosen for an oral presentation at this year’s annual ASH meeting & received the Abstract Achievement Award. I'm so grateful for this recognition & this opportunity to share my research to the #hematology community at #ASH25!
submit.hematology.org/program
submit.hematology.org/program
November 14, 2025 at 6:19 PM
I'm excited to share that my abstract was chosen for an oral presentation at this year’s annual ASH meeting & received the Abstract Achievement Award. I'm so grateful for this recognition & this opportunity to share my research to the #hematology community at #ASH25!
submit.hematology.org/program
submit.hematology.org/program
Reposted by Anna Baj
I'm pleased to share the latest paper from my lab, published online today at @jclinical-invest.bsky.social www.jci.org/articles/vie.... Patients with high risk prostate cancers that resist intense androgen derivation therapy harbor cancer cells that are sensitive to HER2 inhibitors. A "skytorial."
JCI -
Localized high-risk prostate cancer harbors an androgen receptor activity-low subpopulation susceptible to HER2 inhibition
www.jci.org
September 4, 2025 at 4:46 PM
I'm pleased to share the latest paper from my lab, published online today at @jclinical-invest.bsky.social www.jci.org/articles/vie.... Patients with high risk prostate cancers that resist intense androgen derivation therapy harbor cancer cells that are sensitive to HER2 inhibitors. A "skytorial."